World's Largest CRO Leverages Partnership With Integrated Central IBC To Initiate Sites In COVID-19 Vaccine Research At Warp Speed

IQVIA possesses the expertise required to swiftly initiate studies involving genetically engineered therapeutics and vaccines. In collaboration with Advarra, the foremost provider of integrated Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) research review services globally, they joined forces to advance Operation Warp Speed vaccine trials while offering sponsors and clinical research sites an exceptional level of service.

The outcome was the accelerated progress of groundbreaking COVID-19 vaccines and other gene therapies, contributing significantly to lifesaving innovations.